Glucotrack, Inc. Executes 20-for-1 Reverse Stock Split and Announces Public Offering

• Glucotrack, Inc. (NASDAQ:GCTK) executed a 20-for-1 reverse stock split to increase its per-share price.
• The company announced a public offering of approximately 2.6 million shares at $1.15 per share, aiming to raise around $3 million.
• Currently, GCTK is trading at $0.9878, reflecting a 13.35% decrease, with significant volatility observed in its stock price over the past year.

On February 4, 2025, Glucotrack, Inc. (NASDAQ:GCTK) executed a 20-for-1 reverse stock split. Glucotrack is a medical technology company focused on developing innovative solutions for diabetes management. The reverse stock split is a strategic move often used by companies to increase the per-share price by reducing the number of shares outstanding.

In conjunction with the reverse stock split, Glucotrack announced a public offering of approximately 2.6 million shares at $1.15 per share. This offering aims to raise around $3 million before deducting fees and expenses, as highlighted by GlobeNewswire. The closing of this offering is expected around February 5, 2025, subject to standard conditions.

Currently, GCTK is trading at $0.9878, reflecting a 13.35% decrease, with a change of $0.1522. The stock has fluctuated between $0.89 and $2.13 today. Over the past year, GCTK has seen a high of $99 and a low of $0.89, indicating significant volatility in its stock price.

The market capitalization of Glucotrack is approximately $7.68 million, with a trading volume of 41.88 million shares. This volume suggests active trading, which can be influenced by the recent reverse stock split and public offering announcement.